Company profile
ANI PHARMACEUTICALS INC
NASDAQ:ANIPBiotechnology: Pharmaceutical Preparations
Drug pipeline (151)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ACETOHEXAMIDE | approved | — | 0 | — |
| AMINOPHYLLINE | approved | — | 0 | — |
| AMITRIPTYLINE HYDROCHLORIDE | approved | — | 0 | — |
| ANASTROZOLE | approved | — | 32 | approved |
| Acebutolol hydrochloride | approved | — | 0 | — |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (0)
No records yet.
FDA applications (251)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| ANDA 040001 | ANDA | ANI PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 040028 | ANDA | ANI PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 040029 | ANDA | ANI PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 040111 | ANDA | ANI PHARMACEUTICALS INC | ||||
Loading… | ||||||
| ANDA 040255 | ANDA | ANI PHARMACEUTICALS INC | ||||
Loading… | ||||||